RANI Rani Therapeutics Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RANI

Price (delayed)

$7.07

Market cap

$354.61M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.33

Enterprise value

$378.85M

Highlights
The net income has contracted by 11% YoY but it has grown by 4.7% from the previous quarter
The EPS has increased by 6% from the previous quarter but it has decreased by 3.9% YoY
The quick ratio has dropped by 70% year-on-year and by 26% since the previous quarter
The company's equity has shrunk by 65% YoY and by 27% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of RANI
Market
Shares outstanding
50.16M
Market cap
$354.61M
Enterprise value
$378.85M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
27.47
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$28.89M
EBITDA
-$27.02M
Free cash flow
-$52.47M
Per share
EPS
-$1.33
Free cash flow per share
-$2.06
Book value per share
$0.26
Revenue per share
$0
TBVPS
$2.27
Balance sheet
Total assets
$57.92M
Total liabilities
$32.47M
Debt
$30.1M
Equity
$12.87M
Working capital
$42.86M
Liquidity
Debt to equity
2.34
Current ratio
6.36
Quick ratio
6.08
Net debt/EBITDA
-0.9
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-44.1%
Return on equity
-159.4%
Return on invested capital
-31.6%
Return on capital employed
-57.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RANI stock price

How has the Rani Therapeutics Holdings stock price performed over time
Intraday
10.99%
1 week
5.84%
1 month
113.6%
1 year
49.47%
YTD
112.95%
QTD
128.06%

Financial performance

How have Rani Therapeutics Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$66.1M
Net income
-$33.97M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 11% YoY but it has grown by 4.7% from the previous quarter
The operating income has grown by 6% from the previous quarter but it has contracted by 4.2% YoY

Growth

What is Rani Therapeutics Holdings's growth rate over time

Valuation

What is Rani Therapeutics Holdings stock price valuation
P/E
N/A
P/B
27.47
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 6% from the previous quarter but it has decreased by 3.9% YoY
RANI's P/B is 175% above its last 4 quarters average of 9.0
The company's equity has shrunk by 65% YoY and by 27% QoQ

Efficiency

How efficient is Rani Therapeutics Holdings business performance
Rani Therapeutics Holdings's return on equity has shrunk by 135% YoY and by 22% QoQ
The ROA has plunged by 57% YoY and by 11% from the previous quarter
RANI's ROIC is up by 46% YoY

Dividends

What is RANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RANI.

Financial health

How did Rani Therapeutics Holdings financials performed over time
Rani Therapeutics Holdings's total assets is 78% more than its total liabilities
The current ratio has shrunk by 70% YoY and by 26% QoQ
The quick ratio has dropped by 70% year-on-year and by 26% since the previous quarter
The debt is 134% greater than the equity
The company's debt to equity has surged by 185% YoY and by 35% QoQ
The company's equity has shrunk by 65% YoY and by 27% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.